Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015 Apr 16; 372(16):1500-9.
View in:
PubMed
subject areas
Aged
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Anticholesteremic Agents
Cardiovascular Diseases
Cholesterol, LDL
Drug Therapy, Combination
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypercholesterolemia
Male
Middle Aged